You are here

Healthcare Economics & Policy

 

In the past 10 years, Medicare has spent more than $1.5 billion in replacing seven types of defective heart devices, according to the HHS Office of the Inspector General. The same report said patients dished out $140 million in out-of-pocket costs.

Hundreds of thousands of children across the U.K. are learning CPR this week in an effort to combat the country’s “stubbornly low” rates of survival for public cardiac arrests.

Noninferiority trials have dramatically increased in number as researchers try to prove new medical devices and drugs are as safe and effective as established therapies. However, the way these studies are designed and interpreted could use a revamp, a pair of reviewers wrote in The New England Journal of Medicine.

A study of antibiotic delivery methods in France revealed an important finding that could be applied to other pharmaceuticals around the world: patients receiving a per-unit dispensing of pills demonstrated greater adherence to the medication than those receiving prepackaged boxes.

A collection of third-party insurance payers has filed a class-action lawsuit seeking $9.9 million from St. Jude Medical and parent company Abbott Laboratories, claiming St. Jude knew about a battery defect in its cardiac defibrillators nearly five years before issuing a recall.

 

Recent Headlines

You break it, Medicare buys it—and we all pay

In the past 10 years, Medicare has spent more than $1.5 billion in replacing seven types of defective heart devices, according to the HHS Office of the Inspector General. The same report said patients dished out $140 million in out-of-pocket costs.

UK's 'stubbornly' low rates of bystander CPR prompt 'Restart a Heart Day'

Hundreds of thousands of children across the U.K. are learning CPR this week in an effort to combat the country’s “stubbornly low” rates of survival for public cardiac arrests.

NEJM review: Caution needed when interpreting noninferiority trials

Noninferiority trials have dramatically increased in number as researchers try to prove new medical devices and drugs are as safe and effective as established therapies. However, the way these studies are designed and interpreted could use a revamp, a pair of reviewers wrote in The New England Journal of Medicine.

Omitting DNR orders from risk-adjusted mortality measurements could skew rankings

A team of researchers who analyzed rates of do-not-resuscitate (DNR) orders in California are suggesting DNR mortality numbers should be taken into account when calculating hospital risk-adjusted heart failure mortality metrics.

AHA makes 1st-ever statement on meditation: It could be helpful, but no substitute for traditional care

In its first-ever scientific statement on the subject, the American Heart Association said meditation could be a useful treatment tool for cardiac patients, but the organization was careful not to recommend the practice over traditional medical recommendations.

Only 1 in 3 referred for PCSK9 inhibitors can afford them

Just over 30 percent of patients who receive a pricey prescription for the cholesterol-lowering medications known as PCSK9 inhibitors (PCSK9i) are able to pay for the drugs, new research states.

Study: Exact pill dispensing reduces waste, boosts adherence

A study of antibiotic delivery methods in France revealed an important finding that could be applied to other pharmaceuticals around the world: patients receiving a per-unit dispensing of pills demonstrated greater adherence to the medication than those receiving prepackaged boxes.

Lawsuit: St. Jude waited years before recalling faulty defibrillators

A collection of third-party insurance payers has filed a class-action lawsuit seeking $9.9 million from St. Jude Medical and parent company Abbott Laboratories, claiming St. Jude knew about a battery defect in its cardiac defibrillators nearly five years before issuing a recall.

Produce carts seeing increased health benefits for low-income customers

Researchers who surveilled of a handful of “Green Carts” in lower-income regions of New York are suggesting increased access to fresh produce—and the ability to pay for those fruits and vegetables with food stamps—could have a positive effect on overall health in disadvantaged areas.

Discussing the underlying causes of overtreatment

Recent research from PLOS One estimates half of all stents could be unnecessary. No matter how aware and vigilant cardiologists—and, of course all physicians—are in the face of overtreatment, that single statistic is alarming.

Pages